收藏切换
Expression and in vitro and in vivo Activity Study of Anti-human Tumor Necrosis Factor Receptor 2 Monoclonal Antibody
收藏切换
Shimin SUN1, 2, Lili ZHAO1, 2, Zhong LIU3, Guimin ZHANG3, Zhongsong ZHU1, 2, *
Chinese Journal of Pharmaceuticals | 2026, 57(7) : 772 - 781
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2026, 57(7): 772-781
• Paper •
Expression and in vitro and in vivo Activity Study of Anti-human Tumor Necrosis Factor Receptor 2 Monoclonal Antibody
Full
Shimin SUN1, 2, Lili ZHAO1, 2, Zhong LIU3, Guimin ZHANG3, Zhongsong ZHU1, 2, *
Affiliations
  • 1. Lunan New Time Bio-tech Co., Ltd., Linyi 273400
  • 2. State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
  • 3. Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
Published: 2026-07-10 doi: 10.16522/j.cnki.cjph.2026.07.005
Outline
收藏切换

Tumor necrosis factor receptor 2(TNFR2) is highly selectively expressed on tumor cells and regulatory T cells, and represents an important target for tumor immunotherapy. Current TNFR2-targeted drugs encounter developmental bottlenecks such as off-target cross-reactivity and species-specific differences. In this study, a recombinant human TNFR2 monoclonal antibody termed anti-hTNFR2 mAb was generated, and its in vitro and in vivo activities were systematically evaluated. First, through murine immunization, hybridoma screening, complementarity determining region grafting-mediated humanization, and affinity maturation, an anti-hTNFR2 mAb was obtained. After expression and purification, its efficacy was investigated through in vitro activity assays and in vivo studies using mouse solid tumor models.The results showed that the anti-hTNFR2 mAb exhibited high binding affinity(KD=1.18×10-10 mol/L) and blocking activity(IC50=0.037 4 nmol/L), both surpassing those of the positive control antibody 1-H10. Antibody-dependent cell-mediated cytotoxicity of anti-hTNFR2 mAb was quantified via fluorescence-activated cell sorting, yielding an EC50 of 0.078 2 nmol/L, which was superior to that of 1-H10(0.140 2 nmol/L). Collectively, the antibody exhibited significant anti-tumor effects in mice. At a dose of 10 mg/kg, the tumor growth inhibition rate reached 99.1%, outperforming that of 1-H10 (93.9%).

TNFR2  /  monoclonal antibody  /  humanization  /  antitumor activity  /  activity study
孙士民, 赵丽丽, 刘忠, 张贵民, 朱中松. 抗人肿瘤坏死因子受体2单克隆抗体的表达及体内外活性研究. 中国医药工业杂志, 2026 , 57 (7) : 772 -781 . DOI: 10.16522/j.cnki.cjph.2026.07.005
Shimin SUN, Lili ZHAO, Zhong LIU, Guimin ZHANG, Zhongsong ZHU. Expression and in vitro and in vivo Activity Study of Anti-human Tumor Necrosis Factor Receptor 2 Monoclonal Antibody[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (7) : 772 -781 . DOI: 10.16522/j.cnki.cjph.2026.07.005
Year 2026 volume 57 Issue 7
163
50
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.07.005
  • Receive Date:2025-07-04
  • Online Date:2026-11-05
  • Published:2026-07-10
Article Data
Affiliations
History
  • Received:2025-07-04
Funding
Affiliations
    1. Lunan New Time Bio-tech Co., Ltd., Linyi 273400
    2. State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
    3. Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.07.005
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT